Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
4
57%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (33.3%)
N/A4 (66.7%)

Trials by Status

withdrawn114%
completed457%
terminated229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7